Medilux

Medilux is a South Korean biotechnology company specializing in the development of innovative light-responsive drug delivery systems. The company's proprietary platform, Light-Induced Drug Delivery System (LIDDS), utilizes specific wavelengths of light to trigger the precise release of therapeutic agents at targeted sites, such as solid tumors or ocular tissues. This spatiotemporal control aims to maximize therapeutic efficacy while significantly reducing systemic side effects associated with conventional treatments. Medilux is currently advancing a pipeline of nanomedicines, with lead programs focused on oncology and ophthalmology, including treatments for age-related macular degeneration. By combining advanced materials science with photomedicine, the company seeks to provide next-generation solutions for localized and difficult-to-treat diseases.